HIMA Targets French Market While Local European Budgets Cap Technology
This article was originally published in The Gray Sheet
Executive Summary
Overcoming the French government's resistance to reimbursement for implantable cardioverter defibrillators will be a top priority of the Health Industry Manufacturers Association in a planned meeting with French officials in Paris the week of May 17.
You may also be interested in...
Belgian Proposal On Single-Use Device Reuse Puts Onus On Manufacturers
The U.S. should formally object to a proposal by the government of Belgium that places on manufacturers the burden of demonstrating that an approved device for single-use only cannot be reprocessed and resold, the Medical Device Manufacturing Association maintains.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.